Page 2 - க்ரெசந் ஶ்வைட்ஸர் வலேரியா மீனவர் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from க்ரெசந் ஶ்வைட்ஸர் வலேரியா மீனவர். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In க்ரெசந் ஶ்வைட்ஸர் வலேரியா மீனவர் Today - Breaking & Trending Today

DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021


DGAP-News: Vivoryon Therapeutics N.V.: Vivoryon Therapeutics N.V. Reschedules the Reporting of the Full Year 2020 Financial Results to April 30, 2021
Email: vivoryon@trophic.eu
About Vivoryon Therapeutics N.V.
With 20+ years of unmatched understanding in identifying post-translational modifying enzymes that play critical roles in disease initiation and progression, Vivoryon s scientific expertise has facilitated the creation of a discovery and development engine for small molecule therapeutics. This platform has demonstrated success by developing a novel therapeutic in type 2 diabetes. In its current programs Vivoryon is advancing its lead product, varoglutamstat (PQ912), in Alzheimer s disease and its entire portfolio of QPCT and QPCTL inhibitors in oncology and other indications. In addition, the company pursues a development program for Meprin protease inhibitors with potential therapeutic use in fibrotic diseases, cancer and acute kidney injury. www.vivoryon.com ....

Noord Holland , Ulrich Dauer , Halle Saale , Gretchen Schweitzer Valeria Fisher , Company Board Of Directors , News Service , Trophic Communications , Distribution Services , Full Year , Euronext Amsterdam , Corporate News , Regulatory Announcements , Unofficial Market , நூற்த் ஹாலண்ட் , உல்ரிச் அச்சுறுத்தல் , ஹால் ஸேயேல் , க்ரெசந் ஶ்வைட்ஸர் வலேரியா மீனவர் , நிறுவனம் பலகை ஆஃப் இயக்குநர்கள் , செய்தி சேவை , விநியோகம் சேவைகள் , முழு ஆண்டு , பெருநிறுவன செய்தி , ஒழுங்குமுறை அறிவிப்புகள் , அதிகாரப்பூர்வமற்றது சந்தை ,

Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscap


Search jobs
01-Apr-2021
Vivoryon Therapeutics N.V.: Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer s Disease Treatment Options with Leaders and Experts on April 15th, 2021
DGAP-News: Vivoryon Therapeutics N.V.
/ Key word(s): Miscellaneous
01.04.2021 / 07:00
The issuer is solely responsible for the content of this announcement.
Vivoryon Therapeutics to Host Virtual Event on Current Clinical Landscape in Alzheimer s Disease Treatment Options with Leaders and Experts on April 15
th, 2021
HALLE (SAALE) / MUNICH, GERMANY, 1 April 2021 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) (
Vivoryon) announced today that it will host a virtual event covering next steps in Alzheimer s Disease (AD) treatment options with leaders and experts in the field on Thursday, April 15 ....

Ulrich Dauer , Gretchen Schweitzer Valeria Fisher , Philip Scheltens , Howard Feldman , Frank Weber , Dementia Fund , Alzheimer Disease Cooperative Study , Us National Institutes On , Alzheimer Center Amsterdam , Trophic Communications , Department Of Neurosciences , Distribution Services , Host Virtual Event , Current Clinical Landscape , Disease Treatment Options , Euronext Amsterdam , Disease Puzzle , Managing Partner , Disease Cooperative Study , California San Diego School , Chief Medical Officer , European Alzheimer , Disease Phase , Corporate News , Regulatory Announcements , உல்ரிச் அச்சுறுத்தல் ,